Acro Biomedical (ACBM) Revenue (2017 - 2022)

Acro Biomedical's Revenue history runs 6 years deep, the most recent figure standing at $360000.0 for Q4 2022.

• In Q4 2022, Revenue fell 39.8% year-over-year to $360000.0; the TTM figure through Sep 2023 stood at $360000.0 (down 59.84% YoY), while the FY2022 annual figure was $658500.0, down 45.01% from the prior year.
• Revenue was $360000.0 for Q4 2022 at Acro Biomedical, up from $298500.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.4 million in Q3 2018 to a low of $99500.0 in Q1 2021.
• Historically, Revenue has averaged $969181.8 across 5 years, with a median of $598000.0 in 2021.
• The sharpest annual moves came in 2019 and 2022: Revenue plunged 85.71% in 2019, then surged 200.0% in 2022.
• A 5-year view of Revenue shows it stood at $1.4 million in 2018, then slumped by 85.71% to $193536.0 in 2019, then soared by 255.47% to $687964.0 in 2020, then slipped by 13.08% to $598000.0 in 2021, then tumbled by 39.8% to $360000.0 in 2022.
• The last three Revenue figures came in at $360000.0 (Q4 2022), $298500.0 (Q1 2022), and $598000.0 (Q4 2021), per Business Quant data.